EMERYVILLE, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Bionovo, Inc. (Nasdaq: BNVI), a leader in the discovery and development of safe and effective drugs in the areas of women's health and cancer, is scheduled to present at the Bank of Montreal's 2007 Focus on Healthcare Conference.
The presentation by Tom Chesterman, SVP and CFO of Bionovo, Inc., will take place on Wednesday, December 5, 2007 at 1:30 p.m. local time at the Millennium Broadway Hotel in New York City.
To access a live audio webcast and slide presentation of this event, please visit Bionovo's website at http://webcasts.bionovo.com. A webcast replay will become available approximately 24 hours after the presentation ends and will continue to be accessible for six months after the event via Bionovo's website.
Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.
|SOURCE Bionovo, Inc.|
Copyright©2007 PR Newswire.
All rights reserved